English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/168621
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Microvesicles from mesenchymal stromal cells are involved in HPC-microenvironment crosstalk in myelodysplastic patients

AuthorsMuntión, Sandra; Ramos, Teresa L.; Díez-Campelo, María; Rosón, Beatriz ; Sánchez-Abarca, Luis Ignacio; Misiewicz-Krzeminska, Irena; Preciaso, Silvia; Sarasquete, María Eugenia; De Las Rivas, Javier ; González, Marcos ; Sánchez-Guijo, Fermín M.; Cañizo, María Consuelo del
Issue Date2016
PublisherPublic Library of Science
CitationPLoS ONE 11(2): e01466722 (2016)
AbstractExosomes/microvesicles (MVs) provide a mechanism of intercellular communication. Our hypothesis was that mesenchymal stromal cells (MSC) from myelodysplastic syndrome (MDS) patients could modify CD34 cells properties by MVs. They were isolated from MSC from MDS patients and healthy donors (HD). MVs from 30 low-risk MDS patients and 27 HD were purified by ExoQuick-TCor ultracentrifugation and identified by transmission electron microscopy, flow cytometry (FC) and western blot for CD63. Incorporation of MVs into CD34 cells was analyzed by FC, and confocal and fluorescence microscopy. Changes in hematopoietic progenitor cell (HPC) properties were assessed from modifications in micro- RNAs and gene expression in CD34 cells as well as viability and clonogenic assays of CD34 cells after MVs incorporation. Some microRNAs were overexpressed in MVs from patients MSC and two of them, miR-10a and miR-15a, were confirmed by RT-PCR. These microRNAs were transferred to CD34 cells, modifying the expression of MDM2 and P53 genes, which was evaluated by RT-PCR and western blot. Finally, examining CD34 cells properties after incorporation, higher cell viability (p = 0.025) and clonogenic capacity (p = 0.037) were observed when MVs from MDS patients were incorporated. In summary, we show that BM-MSC release MVs with a different cargo in MDS patients compared with HD. These structures are incorporated into HPC and modify their properties.
Publisher version (URL)https://doi.org/10.1371/journal.pone.0146722
URIhttp://hdl.handle.net/10261/168621
Identifiersdoi: 10.1371/journal.pone.0146722
e-issn: 1932-6203
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
microvespatien.PDF6,61 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.